CBT
Price
$88.89
Change
+$0.87 (+0.99%)
Updated
Aug 3, 01:26 PM (EDT)
Capitalization
4.54B
Earnings call today
Intraday BUY SELL Signals
NGVT
Price
$73.11
Change
+$2.92 (+4.16%)
Updated
Jul 31 closing price
Capitalization
2.51B
93 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CBT vs NGVT

CBT vs NGVT Comparison Chart in %
View a ticker or compare two or three
Jul 30, 2026

Which Stock Would AI Choose? Cabot Corporation (CBT) vs. Ingevity Corporation (NGVT) Stock Comparison

Key Takeaways

  • Cabot Corporation (CBT) delivered adjusted earnings per share (EPS) of $7.25 in fiscal 2025, reflecting 3% year-over-year growth despite a challenging macroeconomic backdrop and declining volumes in its Reinforcement Materials segment.
  • Ingevity Corporation (NGVT) is undergoing a significant portfolio transformation, having announced the sale of its Industrial Specialties business for $110 million and exploring strategic alternatives for its Advanced Polymer Technologies (APT) and Road Markings segments.
  • Both companies operate in the specialty chemicals and materials sector, but CBT is heavily tied to tire and automotive production, while NGVT maintains a crown-jewel activated carbon business with EBITDA (earnings before interest, taxes, depreciation, and amortization) margins above 50%.
  • CBT maintains a notably stronger balance sheet with a net debt to EBITDA ratio of 1.2x, compared to NGVT's 2.6x, though the latter has improved leverage by nearly a full turn over the past year.
  • From a trend and stability perspective, NGVT has demonstrated six consecutive quarters of adjusted EBITDA margin expansion, while CBT faces near-term headwinds from elevated Asian tire imports and uncertain tariff environments.

Introduction

Investors seeking exposure to the specialty chemicals and advanced materials space often encounter two distinct names: CBT (Cabot Corporation) and NGVT (Ingevity Corporation). Though both companies produce engineered materials for industrial and automotive end markets, their strategic trajectories, financial profiles, and near-term catalysts differ markedly. Cabot is a well-established global leader in carbon black for tires and specialty chemicals, while Ingevity is reshaping its portfolio around high-margin activated carbon and pavement technologies. This comparison explores how these two stocks stack up in the current market environment, offering perspective for traders and investors evaluating relative positioning in the materials sector.

CBT Overview and Recent Performance

CBT (Cabot Corporation), headquartered in Boston, Massachusetts, is a global specialty chemicals and performance materials company with approximately $3.7 billion in annual revenue and roughly 4,100 employees across 39 manufacturing locations worldwide. The company operates through two primary segments: Reinforcement Materials, which supplies carbon black primarily to the tire industry, and Performance Chemicals, encompassing specialty carbons, battery materials, fumed metal oxides, and aerogel products.

In recent market activity, Cabot has navigated a demanding macroeconomic landscape with mixed results. The company generated $665 million in operating cash flow in its most recent fiscal year, supported by strong capital discipline that enabled $96 million in dividend payments and $168 million in share repurchases. However, revenue declined year-over-year as global Reinforcement Materials volumes contracted, pressured by elevated tire imports from Asia into Western markets and softer demand in the Americas and Asia Pacific regions. On a positive note, the Performance Chemicals segment showed resilience, with battery materials revenue growing approximately 20% year-over-year, driven by demand for conductive carbons used in energy storage applications. The company also announced an agreement to acquire Bridgestone's reinforcing carbons plant in Mexico, a move expected to strengthen its North American manufacturing footprint. Looking ahead, management has guided for adjusted EPS in the range of $6.00 to $7.00 for the coming fiscal year, reflecting an uncertain trade environment and ongoing competitive headwinds.

NGVT Overview and Recent Performance

NGVT (Ingevity Corporation), headquartered in North Charleston, South Carolina, is a specialty materials company operating across three segments: Performance Materials (activated carbon for automotive emissions control), Advanced Polymer Technologies (caprolactone-based specialty polymers), and Performance Chemicals (pavement technologies and road markings). The company employs approximately 1,500 people across 24 locations globally.

Ingevity's recent performance has been defined by aggressive portfolio repositioning. The company announced the sale of the majority of its Industrial Specialties product line and its North Charleston crude tall oil refinery for $110 million, with proceeds directed toward debt reduction. Simultaneously, management revealed it is exploring strategic alternatives for the Advanced Polymer Technologies and Road Markings segments. The core of the "New Ingevity" strategy centers on two industry-leading businesses: Performance Materials, which generates EBITDA margins above 50% from automotive activated carbon, and Pavement Technologies, where the company holds a dominant position in warm-mix asphalt additives. In recent quarters, Ingevity delivered its sixth consecutive period of year-over-year adjusted EBITDA margin expansion, reaching 33.5%, while reducing net leverage from 3.5x to 2.6x. Free cash flow generation reached a five-year high, enabling share repurchases and accelerated deleveraging. For the coming year, management projects adjusted EPS of $4.80 to $5.20 on approximately $1.1 billion to $1.2 billion in net sales from continuing operations.

Trending AI Robots

For traders seeking an analytical edge in evaluating stocks like CBT and NGVT, Tickeron's Trending AI Robots page offers access to a curated selection of AI-driven trading bots. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers across equities, ETFs, forex, and cryptocurrencies, but only the top-performing strategies aligned with current market conditions earn a place in this featured section. These bots span diverse trading styles — from short-term 5-minute and 15-minute signal agents to longer-duration swing-trading and trend-following systems — and have historically posted annualized returns ranging from approximately 78% to over 290% among leading strategies. Key performance metrics such as Sharpe ratios, drawdown levels, profit factors, and trade frequency are all transparently displayed, allowing users to evaluate risk-adjusted returns. To explore which AI-powered strategies are currently trending and suitable for today's markets, visit the Trending AI Robots page.

Head-to-Head Comparison

When placed side by side, CBT and NGVT present contrasting investment profiles across several key dimensions:

Business Model and End-Market Exposure: Cabot is deeply tied to global tire production and automotive manufacturing cycles through its Reinforcement Materials segment, which accounts for the majority of revenue. Ingevity's Performance Materials segment also serves the auto industry — specifically evaporative emission control systems — but benefits from regulatory tailwinds (increasing emissions standards) and a growing hybrid vehicle mix that requires more activated carbon content per vehicle. NGVT's Pavement Technologies segment adds infrastructure-linked diversification not present in CBT's portfolio.

Balance Sheet Strength: Cabot holds a clear advantage with a net debt to EBITDA ratio of 1.2x and total liquidity of approximately $1.5 billion, providing substantial flexibility for capital returns and strategic investments. Ingevity has made impressive progress reducing leverage from 3.5x to 2.6x, but remains more levered than Cabot and is still working toward its target range of 2.0x to 2.5x.

Growth Drivers: Cabot's growth narrative centers on battery materials, where contribution margin grew 20% year-over-year, alongside the Mexico acquisition. Ingevity's growth story revolves around its warm-mix asphalt technology (Evotherm), filtration market expansion, and steadily rising activated carbon content per vehicle as global emissions standards tighten.

Risk Factors: CBT faces near-term pressure from Asian tire import competition and tariff-related demand uncertainty. NGVT carries execution risk from its ongoing portfolio restructuring, including the divestiture of non-core businesses and strategic reviews that could introduce earnings volatility. Both companies are exposed to global auto production trends, which have remained below prior peaks.

Tickeron AI Verdict

Based on observable factors such as trend consistency, margin trajectory, and strategic catalysts, Tickeron's AI analytical framework would likely tilt in favor of NGVT (Ingevity Corporation) in the current environment. The six consecutive quarters of EBITDA margin expansion signal a persistent positive trend, while the portfolio simplification toward two high-margin, technology-differentiated businesses reduces complexity and sharpens the growth narrative. The company's improving free cash flow generation and rapid deleveraging further strengthen the case for relative stability. That said, CBT (Cabot Corporation) offers a compelling value proposition through its fortress balance sheet, consistent shareholder returns, and battery materials growth potential — factors that may appeal to a different class of risk-conscious investors. In probabilistic terms, NGVT's restructuring momentum and margin leadership present a slightly more favorable risk-reward profile for trend-oriented strategies, while CBT's discounted valuation and cash flow durability may attract those prioritizing capital preservation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
CBT vs. NGVT commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBT is a Hold and NGVT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (CBT: $88.02 vs. NGVT: $73.11)
Brand notoriety: CBT and NGVT are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: CBT: 83% vs. NGVT: 109%
Market capitalization -- CBT: $4.54B vs. NGVT: $2.51B
CBT [@Chemicals: Specialty] is valued at $4.54B. NGVT’s [@Chemicals: Specialty] market capitalization is $2.51B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $221.18B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $11.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBT’s FA Score shows that 2 FA rating(s) are green whileNGVT’s FA Score has 2 green FA rating(s).

  • CBT’s FA Score: 2 green, 3 red.
  • NGVT’s FA Score: 2 green, 3 red.
According to our system of comparison, CBT is a better buy in the long-term than NGVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBT’s TA Score shows that 4 TA indicator(s) are bullish while NGVT’s TA Score has 6 bullish TA indicator(s).

  • CBT’s TA Score: 4 bullish, 4 bearish.
  • NGVT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NGVT is a better buy in the short-term than CBT.

Price Growth

CBT (@Chemicals: Specialty) experienced а -2.36% price change this week, while NGVT (@Chemicals: Specialty) price change was -0.20% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +1.40%. For the same industry, the average monthly price growth was -1.39%, and the average quarterly price growth was +3.90%.

Reported Earning Dates

CBT is expected to report earnings on Aug 03, 2026.

NGVT is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Chemicals: Specialty (+1.40% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CBT($4.54B) has a higher market cap than NGVT($2.51B). NGVT has higher P/E ratio than CBT: NGVT (102.97) vs CBT (16.61). CBT YTD gains are higher at: 34.317 vs. NGVT (23.538). CBT has higher annual earnings (EBITDA): 752M vs. NGVT (207M). CBT has more cash in the bank: 252M vs. NGVT (97.4M). NGVT (1.24B) and CBT (1.3B) have identical debt. CBT has higher revenues than NGVT: CBT (3.58B) vs NGVT (1.16B).
CBTNGVTCBT / NGVT
Capitalization4.54B2.51B181%
EBITDA752M207M363%
Gain YTD34.31723.538146%
P/E Ratio16.61102.9716%
Revenue3.58B1.16B308%
Total Cash252M97.4M259%
Total Debt1.3B1.24B105%
FUNDAMENTALS RATINGS
CBT vs NGVT: Fundamental Ratings
CBT
NGVT
OUTLOOK RATING
1..100
587
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
4818
PRICE GROWTH RATING
1..100
4344
P/E GROWTH RATING
1..100
1215
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBT's Valuation (30) in the Industrial Specialties industry is significantly better than the same rating for NGVT (98) in the Chemicals Major Diversified industry. This means that CBT’s stock grew significantly faster than NGVT’s over the last 12 months.

CBT's Profit vs Risk Rating (62) in the Industrial Specialties industry is somewhat better than the same rating for NGVT (100) in the Chemicals Major Diversified industry. This means that CBT’s stock grew somewhat faster than NGVT’s over the last 12 months.

NGVT's SMR Rating (18) in the Chemicals Major Diversified industry is in the same range as CBT (48) in the Industrial Specialties industry. This means that NGVT’s stock grew similarly to CBT’s over the last 12 months.

CBT's Price Growth Rating (43) in the Industrial Specialties industry is in the same range as NGVT (44) in the Chemicals Major Diversified industry. This means that CBT’s stock grew similarly to NGVT’s over the last 12 months.

CBT's P/E Growth Rating (12) in the Industrial Specialties industry is in the same range as NGVT (15) in the Chemicals Major Diversified industry. This means that CBT’s stock grew similarly to NGVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBTNGVT
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
64%
Momentum
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
67%
MACD
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
70%
Advances
ODDS (%)
Bullish Trend 6 days ago
68%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
CBT
Daily Signal:
Gain/Loss:
NGVT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DAMD1.720.05
+2.99%
Defiance Daily Target 2X Short AMD ETF
TSLG3.620.05
+1.40%
Leverage Shares 2X Long TSLA Daily ETF
NCZ15.460.20
+1.31%
Virtus Convertible & Income Fund II
EWP61.480.04
+0.07%
iShares MSCI Spain ETF
GABF45.310.03
+0.06%
Gabelli Financial Services Opp ETF